Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASEPTIC: Co-trimoxazole for SBP Prophylaxis in Cirrhosis
NCT04395365Phase 3Unknown
- Sponsor
- University College London
- Start
- Jun 2019
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of trimethoprim + sulfamethoxazole in spontaneous bacterial peritonitis (SBP), sponsored by University College London. Status: unknown.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT04395365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04395365.